Mikhail Petrovich Kostinov (M P Kostinov, Mikhail Kostinov, Michail Kostinov)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Coronavirus Disease

Immune Response

Dendritic Cells

Top Venues

Scientific reports

Terapevticheskii arkhiv

Voprosy pitaniia

This page only lists publications with an associated author ORCID identifier.

Publications

Mikhail Petrovich Kostinov, Oksana Svitich, Alexander Chuchalin, Valery Osiptsov, Ekaterina Khromova, Natalya Abramova, Vitaly Tatevosov, Anna Vlasenko, Sergey N Avdeev, Dmitrij Pakhomov, Kirill Mashilov, Tatyana Ospelnikova, Natalya Mihajlova, Valentina Polishchuk, Ekaterina Kurbatova, Aristitsa Mikhailovna Kostinova
Secretory IgA and course of COVID-19 in patients receiving a bacteria-based immunostimulant agent in addition to background therapy. Scientific reports 14 (1) (2024)
Mikhail Petrovich Kostinov, Oksana Svitich, Alexander Chuchalin, Valery Osiptsov, Ekaterina Khromova, Natalya Abramova, Vitaly Tatevosov, Anna Vlasenko, Sergey N Avdeev, Dmitrij Pakhomov, Kirill Mashilov, Tatyana Ospelnikova, Natalya Mihajlova, Valentina Polishchuk, Ekaterina Kurbatova, Aristitsa Mikhailovna Kostinova
Secretory IgA and course of COVID-19 in patients receiving a bacteria-based immunostimulant agent in addition to background therapy. Scientific reports 14 (1) (2024)
Mikhail Petrovich Kostinov, Oksana Svitich, Alexander Chuchalin, Valery Osiptsov, Ekaterina Khromova, Natalya Abramova, Vitaly Tatevosov, Anna Vlasenko, Sergey N Avdeev, Dmitrij Pakhomov, Kirill Mashilov, Tatyana Ospelnikova, Natalya Mihajlova, Valentina Polishchuk, Ekaterina Kurbatova, Aristitsa Mikhailovna Kostinova
Secretory IgA and course of COVID-19 in patients receiving a bacteria-based immunostimulant agent in addition to background therapy. Scientific reports 14 (1) (2024)
Ronald Kompier, Pieter Neels, Walter Beyer, Timothy Colin Hardman, Dmitry Lioznov, Susanna Kharit, Mikhail Petrovich Kostinov
Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine. F1000Research 11 (2022)
Ronald Kompier, Pieter Neels, Walter Beyer, Timothy Colin Hardman, Dmitry Lioznov, Susanna Kharit, Mikhail Petrovich Kostinov
Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine. F1000Research 11 (2022)
Oksana Svitich, I A Baranova, Nadezhda V Kryukova, Alexander V Poddubikov, A B Vinnitskaya, Natalya Abramova, V V Zakharova, L V Shogenova, Mikhail Petrovich Kostinov, A G Chuchalin
[Hydrogen effect on the mechanisms of mucosal immunity in patients with COVID-19]. Terapevticheskii arkhiv 94 (3) (2022)
A A Dzhumagaziev, Mikhail Petrovich Kostinov, D A Bezrukova, O V Usaeva
[Possible mechanisms of impaired post-vaccination immune response in obesity]. Voprosy pitaniia 90 (5) (2021)
Mikhail Petrovich Kostinov, Alexander Petrovich Cherdantsev, Alexei Isaevich Kuselman, Nelli Kimovna Akhmatova, Aristitsa Mikhailovna Kostinova, Elena Viktorovna Deryabina, Evgeniia Olegovna Demina
Prospective randomized open-label comparative study of immunogenicity after subunit and polymeric subunit influenza vaccines administration among mothers and infants. Human vaccines & immunotherapeutics 14 (12) (2018)